© Copyright Nostre Net
The non-invasive nature of optical
coherence tomography (OCT) and its ability to generate a false-color depiction
of tissue structure has made the global market for OCT highly lucrative. OCT is
comparable to ultrasound imaging, with the principal difference that the
technology uses light instead of sound. Research & development of the
technology has led to efficient, fast and accurate OCT devices which have
branched out from ophthalmology to include medical applications in dermatology,
and cardiology among others, thus facilitating growth. Market Research Future's
report on the Optical
Coherence Tomography Market trends to gain a valuation of USD 15.50
Billion by 2030 at 15.5% CAGR.
Prevalence of eye diseases and the rising
occurrence of cardiac conditions have motivated market growth. Rising demand
for OCT has led to R&D for technological advancements which in turn is
expected to increase market growth further. Presently, although there are many
applications for OCT devices, they are primarily used in ophthalmology, this
indicates unrealized potential yet to be explored which will likely push demand
for this technology in the coming years.
High costs associated with portable optical
coherence tomography may hamper growth. However, increasing use in various
applications, supportive government regulations and favorable reimbursements
are likely to mitigate this challenge to a great extent.
Regional Analysis
The Americas hold the largest share with
nearly 37% of the global market share. Increasing occurrence of diabetic
retinopathy and other eye diseases is one of the key factors driving the growth
of the market. Moreover, there is a strong presence of market leaders. MRFR as
predicted that region will reach an evaluation of approximately USD 558.34
million by 2023.
Europe follows the Americas lead and is
expected to maintain a strong second lead due to supportive government policies
and research & development carried out by private players is the primary
propeller for the growth of the OCT market over the forecast period. The region
is expected to closely follow the growth pattern of the Americas.
The Asia-Pacific region, is predicted to be
the fastest growing region with a CAGR of 9.4% during the forecast period. A
massive patient population in the region with a rising incidence of eye
diseases and diabetic retinopathy is expected to fuel rapid growth for the
region. International market leaders are trying to enter this region, and this
is likely to facilitate growth in the coming years further.
The Middle East & Africa are expected
to experience limited growth. This is primarily due to the passive development
in the African continent.
Market Segmentation
The optical
coherence tomography market report has been segmented by technology,
application, type of devices and region.
By technology, the market has been
segmented into spectral-domain OCT (SD-OCT), swept-source OCT, and others. The
SD-OCT segment is predicted to dominate with approximately 60% share of the
total market during the forecast period. Meanwhile, swept-source OCT is the
fastest growing segmented and is expected to grow at CAGR of 9.1% during the
review period.
By application, the market has been
segmented into cardiology, ophthalmology, dermatology, oncology, and others.
Ophthalmology has the most significant segment with over 53% of the market
share. However, dermatology is the fastest growing application segment and is
expected to grow at a considerable 9.3% CAGR during the forecast period.
By type of devices, the market has been
segmented into handheld OCT devices, tabletop OCT devices, catheter-based OCT
devices, and others.
By region, the market has been segmented
into the Americas, Europe, Asia Pacific and the Middle East and Africa.
Key Players
Market leaders have been featured in the
report to provide a comprehensive understanding of the competitive landscape.
Prominent players included in the report are Imalux Corporation, Optovue,
Michelson Diagnostics, Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo
Corporation, KONINKLIJKE PHILIPS N.V, B. Braun Melsungen AG, Boston Scientific
Corporation, OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Topcon
Corporation, NIDEK Co., Ltd, Novacam Technologies Inc, Thorlabs Inc., and Agfa
Healthcare
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Pediatric Vaccines Market Overviewand analysis by Type, Technology, Application
and Region Forecast till 2030.
Vaccines administered to children to
prevent them from several infectious and non-infectious diseases are referred
to as pediatric vaccines. They are either heat-killed or inactivated viruses
which lose their pathogenicity. These inactivated antigens stimulate the immune
system so that they can produce antibodies against the infected virus.
The pediatric vaccines market is expected to reach USD 35.52 Billion
by 2030 at 9.90% CAGR during the forecast period 2022-2030.
Potential and Pitfalls
Various pediatric vaccines available in the
market are hepatitis B antibody, flu immunization, meningococcal immunization,
pneumococcal immunization, rotavirus immunization, Hib antibody, polio
antibody, and MMR immunization. With growing economic growth, rising awareness
associated with the benefits of vaccination in prevention of diseases, and
favorable reimbursement, the global market for pediatric vaccine is anticipated
to flourish during the estimated period. The growing collaboration of local
manufacturers with the major market players to deliver high-quality vaccines in
the remote areas are further considered to foster the market growth in the
coming years. Moreover, high prevalence of chronic diseases is one of the key
factors boosting the global market. Infants are more prone to severe diseases,
and therefore vaccination plays an important role in their prevention.
Competitive Dashboard
The major players operating the global pediatric
vaccines market are Zydus Cadila (India), S K Chemicals (South Korea),
AstraZeneca (UK), Bio Med (India), Sanofi Pasteur SA (France), Bharat Biotech
(India), Shenzhen Kangtai Biological Products (China), Sinovac Biotech (China),
Pfizer Inc. (U.S.), Nuron (U.S.), CSL Limited (Australia), Merck & Co. Inc.
(U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan),
Protein Sciences Corporation (U.S.), Dynavax Technologies (U.S.), LG Life
Sciences (India), Kaketsuken (U.S.), Emergent BioSolutions Inc. (U.S.), Crucell
(Netherlands), GlaxoSmithKline plc (U.K.), Grifols (Spain), Bharat
Immunologicals and Biologicals (India), Lupin Pharmaceuticals, Inc. (India),
Panacea Biotec (India), Serum Institute of India Pvt. Ltd. (India), Bavarian
Nordic (Denmark), Novartis AG (Switerzland), Astellas Pharma Inc. (Japan),
Johnson & Johnson (U.S.), bioCSL Inc. (U.S.), Takeda Pharmaceutical
(Japan), MedImmune LLC (U.S.), Indian Immunologicals (India), Baxter
International (U.S.), Valeant Pharmaceuticals (U.S.) and others.
Global Pediatric Vaccines Market:
Segmental Analysis
The global pediatric vaccines market has
been segmented on the basis of technology, type, route of administration,
disease indication, and region.
By mode of type, the global pediatric
vaccines market is segmented into multivalent vaccines, monovalent vaccines,
and others.
By mode of technology, the global pediatric
vaccines market is segmented into conjugate vaccines, dendritic cells vaccines,
pediatric mobility devices, recombinant vaccines, inactivated and subunit
vaccines, live attenuated vaccines, synthetic vaccines, toxoid vaccines, and
others. Among these, the conjugate vaccines segment is likely to dominate the
market owing to the increasing prevalence of meningococcal and pneumococcal
infections.
By mode of disease indication, the global
pediatric vaccines market is segmented into hepatitis, meningococcal disease,
MMR (measles, mumps, and rubella), rotavirus, polio, combination vaccines,
varicella, pneumococcal disease, haemophilus influenza type B, influenza, DTP
(diphtheria, tetanus, pertussis), and others.
By mode of route of administration, the
global pediatric vaccines market is segmented into subcutaneous administration,
intramuscular administration, oral administration, and others.
Regional Insights
Geographically, the pediatric
vaccines market research report span across regions namely, Europe,
America, the Middle East and Africa, and the Asia Pacific region.
Among all the regions, America is
considered to hold the largest market share and is likely to maintain its dominance
during the assessment period. The growth is mainly attributed to the increasing
initiatives taken by the U.S. Department of Health and Human Services in order
to minimize the occurrence rate of infectious diseases
Europe is presumed to register a significant
growth rate owing to the superior government spending like the National Health
Service for the deployment of medical and pharmaceutical industries.
Asia Pacific is estimated to expand at a
rapid pace owing to the increasing healthcare sector in the leading regions
such as India and China. The Middle East and African region are also likely to
expand at a steady pace due to extensive research and development activities
coupled with the development in the healthcare infrastructure in this region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Seborrheic Keratosis is a non-cancerous
skin condition that is common in older adults. Skin growths on shoulders,
back, abdomen, scalp, face, and chest may appear when suffering from the
disease. The Seborrheic
Keratosis Market trends is projected to reach USD 3.4 Billion by 2030 at
5.80% CAGR during the forecast period 2022-2030, asserts Market Research Future
in an extensive study. Elevating consumer inclination towards aesthetics and
growing awareness regarding physical appearance urge people to opt for the
treatment of Seborrheic keratosis. Seborrheic keratosis can be easily treated
with Cryosurgery where liquid nitrogen is used to prevent further growth. Also,
in recent years, surgeries involving cosmetic procedures have entered the
mainstream which spurs the growth of the market.
Notable improvements in treatment methods
and the availability of diverse treatment options have contributed to the
growth of the market. Other driving factors include extensive R&D efforts,
surging prevalence of the disease, improving reimbursement scenario and
availability of cost-effective treatment options. Conversely, the growth of the
global Seborrheic Keratosis market might be hampered by post-surgery side
effects, high costs associated with treatment which might limit market growth
in price-sensitive and developing regions.
Competitive Landscape
The notable players in the global Seborrheic
keratosis market include Quantumpm, Becton Dickinson and Company, Quanta
Systems S.p.A., Aclaris Therapeutics, THOR Photomedicine, Syneron Medical Ltd.,
Cutera, Angiodynamics, Inc., Erchonia Corporation, Valeant, Lumenis, BioLight
Technologies LLC, Alma Lasers, KAI Medical, IRIDEX Corp., Integra Miltex,
Coherent, Inc., Apira Science Inc., Biolase Inc., and Theralase Inc.
Segmentation
The global Seborrheic keratosis market has
been segmented based on type, diagnosis, treatment, and end user.
By type, the global Seborrheic keratosis
market has been segmented into stucco keratosis, inverted follicular keratosis,
reticulated Seborrheic keratosis or adenoid seborrheic keratosis, clonal
seborrheic keratosis, seborrheic keratosis with squamous atypia,
melanoacanthoma, dermatosis papulosa nigra, seborrheic keratosis, and irritated
seborrheic keratosis.
The common seborrheic keratosis segment has
been further segmented into basal cell papilloma and solid seborrheic keratosis.
The stucco keratosis segment has been
further segmented into digitate seborrheic keratosis, serrated seborrheic
keratosis, verrucous seborrheic keratosis, and hyperkeratotic seborrheic
keratosis.
By diagnosis, the global seborrheic
keratosis market has been segmented into skin biopsy and others.
By seborrheic keratosis treatment, the
global seborrheic keratosis market has been segmented into surgical procedures,
medication, medical procedures, seborrheic keratosis treatment and others. The
surgical procedures segment has been further segmented into cryosurgery,
electrocautery or electrosurgery, curettage, and others. The medical procedures
segment has been further segmented into freezing, tissue scraping, laser
therapy, and others.
By end user, the global the global
seborrheic keratosis market has been segmented into hospital, clinics,
diagnostic centers, pharmacies, and others.
Regional Analysis
The Americas, Europe, Asia Pacific (APAC),
and the Middle East & Africa (MEA) are the key markets for seborrheic
keratosis. The Americas dominate the global seborrheic
keratosis market report on account of surging awareness regarding the
condition among the consumers and high expenditure on healthcare. The
prevalence of seborrheic keratosis is also considerably high in the region
which generates high demand for diagnosis and treatment. As per a report
published in the Journal of Drugs in Dermatology in 2015, seborrheic keratosis
affects more than 83 Mn Americans.
Europe commands the second largest position
in the global seborrheic keratosis market. government support in the form of
funding for R&D, the presence of private organizations who are engaged in
extensive R&D and favorable reimbursement policies in the region drive the
growth of the Europe Seborrheic keratosis market.
APAC is projected to be the fastest growing
market for Seborrheic Keratosis. Presence of a vast patient pool, development
of healthcare technology and the growing participation of market players in the
region are stimulating the growth of the APAC market.
The MEA market is expected to account for
the least share of the global market due to lack of medical facilities and
affordability in the region. Moreover, the lack of awareness about the
condition is also a market deterrent.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Insights
The chronic
kidney disease market trends is expected to grow at a CAGR Of 5.40% during
the forecast period 2022-2030. Rising occurrences of chronic diseases and the
severity of kidney disease has increased the demand for an effective treatment
option for the disease. Causes of chronic diseases are often indicated by
diabetes, polycystic kidney disease, and high blood pressure among others.
Increasing R&D activities with regards
to diagnostics and treatment are expected to offer market growth opportunities
in the future. Moreover, developing economies offer a wider scope for growth
during the forecast period and are expected to affect the market positively.
Increasing prevalence of kidney diseases
and the increased number of biopsy procedures have resulted in high demand for
new diagnostic and treatment options for such chronic diseases. The global chronic
kidney disease market has become highly competitive with the increasing entry
of new market players; this is expected to stimulate growth during the forecast
period. Kidney disease symptoms are often negligible in the initial phases, and
this type of disease is widely referred to as a "silent disease" as
detection often happens when the diseases are progressed to a later stage. This
has increased the need for appropriate diagnostic measures and is driving
market growth.
Regional Analysis
The Americas and Europe are significant
regional markets which have a similar growth pattern. The growth of medical
devices, increasing awareness regarding kidney diseases and the rapid increase
in occurrences of chronic diseases is expected to drive growth in these
regions. Moreover, they display a robust demand for new treatment methods and
options. Opportunities for these markets are being driven by the increasing
emphasis on the development of new drugs. Supportive government legislature
with regards to research & development and the availability of funds for
research in these regions is expected to push the market in a forward
direction.
Asia-Pacific is another important market
due to its rapid growth. Prevalence of diseases such as diabetes and
cardiovascular diseases are driving the demand for appropriate treatment
options. The region has a rapidly improving healthcare sector which has
improved infrastructure, and a wide pool of skilled healthcare professionals.
Demand for advanced treatment technologies and other healthcare technology is
expected to provide the market with opportunities for market expansion.
Market Segmentation
MRFR's the global chronic
kidney disease market report segments on the basis of diagnosis, treatment,
indication, and end-user. By diagnosis, the market is segmented into blood
test, urine test, imaging test, and kidney biopsy. By treatment, the market is
segmented into drugs, dialysis, and kidney transplant. Drugs are further
sub-segmented to include ace inhibitors, angiotensin-ii receptor blockers,
calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.
By indication, the market is segmented into
Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and
others. By end-user, The market is segmented into hospitals and clinics,
diagnostic centers, and others. Globally, the market is divided into the
Americas, Europe, Asia-Pacific & the Middle East and Africa.
Key Players
MRFRs report includes the analysis of
market players participating in the global chronic kidney diseases competitive
landscape. Top market players include Hoffman-La Roche Ltd., Abbott,
AstraZeneca Plc, Pfizer, Nova Biomedical, ARKRAY, OPTI Medical, and AbbVie to
name a few.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Synopsis:
The Dietary
Supplements in the Age of Personalized Nutrition Market is expected to
reach USD 21,198.44 Million by 2030 at 6.70% CAGR during the forecast period
2022-2030.Increasing awareness regarding the necessity of nutrients in daily
diet and rise in popularity of fitness programs are primarily propelling the
expansion of the global dietary supplements in the age of personalized
nutrition market. Increasing incorporation of technologically advanced research
and manufacturing processes in the pharmaceutical and healthcare industry along
with the high demand for personalized medication are also fueling the growth of
the global dietary supplements in the age of personalized nutrition market.
However, concerns regarding the side effects cause by these supplements are
likely to act as restraining factors for the growth of the global dietary
supplements in the age of personalized nutrition market during the forecast
period.
Regional Analysis:
The global dietary supplements in the age
of personalized nutrition market has been geographically segmented into four
major regions such as the Americas, Europe, Asia Pacific and the Middle East and
Africa. Among these, the Americas command for the major share in the global
dietary supplements in teh age of personalized nutrition market owing to the
presence of leading manufacturers, high healthcare expenditure by the
population of this region and utilization of advanced technology for the
production of personalized drugs and supplements in this region. Increased
research in the nutrition industry for the development of personalized dietary
supplements by studying the DNA, dietary habits and other factors in an
individual is majorly propelling the expansion of teh dietary supplements in
the age of personalized nutrition market. Improving economic conditions,
increasing geriatric population, government support for research and
development in teh healthcare sector and rise in awareness regarding the health
benefits of dietary supplements are boosting the dietary supplements in the age
of personalized drugs market in the Asia Pacific region. Whereas, low
penetration of proper healthcare services and lack of awareness among the
population of the underdeveloped regions are leading to the slow growth of the
dietary supplements in the age of personalized nutrition market in the Middle
East and Africa market.
Market Segmentation:
The global dietary supplements in the age
of personalized nutrition market has been segmented on the basis of product
category, gender, application, dosage form and end user. Based on product
category, the market has been segmented into vitamins, herbs & botanicals,
sports supplements, dietary supplements ingredients, meal supplements, minerals
and other. Based on application, the market has been segmented into lifestyle
diseases, inherited diseases, genetic predispositions and others. Based on
gender, the market has been segmented into female and male. The female segment
has been sub-segmented into 55 + age group, 35-54 age group, 19-34 age group,
and 0-18 age group. The male segment has also been sub-segmented into 55 + age
group, 35-54 age group, 19-34 age group, and 0-18 age group. Based on dosage
form, the market has been segmented into tablets, capsules, powder, liquids,
soft gels and others. Based on end users, the market has been segmented into
hospitals & clinics, home care, and others.
Key Players:
The profiled by MRFR that are operating in
the global dietary
supplements in the age of personalized nutrition market players are Nestlé
Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer
Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco,
Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation,
Natures Product Inc., Bactolac Pharmaceutical Inc. and others.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Diabetic Nephropathy Market Overviewand Analysis By Diagnosis, By Treatment, By
Indication, By End User, Forecast Till 2030
Diabetic Nephropathy Market was valued USD
2.48 billion in 2021 and is expected to reach USD 3.43 billion by 2030 at 6.20%
CAGR during the forecast period 2022-2030. This can be attributed to
rising cases of obesity and diabetes. Immense demand for diagnostic and
imaging tests such as kidney biopsy, blood test, urine test, CT scan, and MRI
scans can fuel the market demand. According to the World Health Organization,
patients with chronic diseases touched a high of 35 million globally.
Diabetic nephropathy, known as diabetic
kidney disease (DKD), is a kidney malady frequently found in patients with type
1 and type 2 diabetes. High prevalence of diabetes globally has culminated in
diabetes co-morbidities. It can cause nephropathy which would require dialysis
or a transplant. The global diabetic nephropathy market report by Market
Research Future (MRFR) provides a quantitative and qualitative analysis by
listing out trends, factors, and restraints with ample figures and statistics
to back up the evidence.
Technological advances in diagnostic
imaging and emphasis on early diagnosis for prevention of diseases are other
drivers of the market. The expansion of the healthcare sector and availability
of these tests at reputed hospitals and clinics can lend credibility to the
trend. Rising number of clinical trials conducted to test the success of drugs
for inhibiting the progress of DKD can provide new growth avenues. Angiotensin
converting enzyme inhibitors (ACEi) have been known to have moderate success in
clinical trials with placebo treatment in reducing the risk of death in
patients with diabetes.
Competitive Outlook
Bayer AG, Siemens AG, AbbVie Inc., Eli
Lilly and Company, Mitsubishi Tanabe Pharma Corporation, Reata Pharmaceuticals,
Inc., Pfizer Inc., Abbott, Merck & Co., Inc., General Electric Company,
Novartis AG, Sanofi, and others are some of the noteworthy players in the
global diabetic nephropathy market. Increased investments in research and
development and drug discovery pertaining to chronic kidney disorders are the
main focus of these players.
Segmentation Analysis
The global diabetic
nephropathy market Outlook is segmented by diagnosis, treatment,
indication, and end-user.
By diagnosis, it is segmented into imaging
tests, urine tests, blood tests, renal function testing, and kidney biopsy. By
treatment, it is segmented into kidney dialysis, medications, and transplant.
By indication, it is segmented into diabetes 1 and diabetes 2. By end-user, it
is segmented into research institutes, hospitals & clinics, diagnostic
centers, and others.
Regional Analysis
Europe, the Americas, Asia Pacific (APAC),
and the Middle East & Africa (MEA) are regions covered in the diabetic
nephropathy market report.
The Americas are pegged to lead the global
market till 2023 due to emphasis on diagnostic tests, constant monitoring of
insulin levels, and large prevalence of chronic kidney disease (CKD). According
to the U.S. National Chronic Kidney Disease, nearly 39 million Americans have
CKD as of 2019. Large awareness levels can drive the regional market demand.
This is exemplified with the American Diabetes Association for creating
programs among diabetics for diabetes management.
The European region is deemed to be driven
by kidney diagnosis tests for the geriatric populace combined with demand for
diagnostic services. Germany is touted to be one of the biggest regions due to
investment in new technologies and favorable reimbursement policies. High
awareness of diabetes and its negligence which can cause kidney disorders is
likely to drive the regional diabetic nephropathy market.
On the other hand, the APAC region is the
third biggest globally and will sustain its ranking till the end of the
forecast period. High prevalence of diabetes in Thailand, China, Japan, and
India combined with chances of DKD in the region due to low patient awareness
levels can work favorably for the market. The large geriatric population in
these countries can also count as a viable factor driving the global diabetic
nephropathy market growth.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
An
insightful report furnished by Market Research Future (MRFR) suggests that the
Asia Pacific (APAC) Aesthetics Market is poised to grow at an approximate
growth rate of 11.50% during the forecast period (2017-2023).
The
importance of beauty and personal appearance currently is at an all-time high
as compared to earlier times due to the development of social media
proliferation, thus boosting the Asia Pacific Aesthetics Market. Reportscreated by MRFR detail the developments in the industry that can be
expected in the market through the forecast period. The Asia
Pacific Aesthetics Market trends is estimated to gain a strong assessment
of USD 12,175.1 MN by the conclusion of 2025.
The breakthroughs in non-invasive
procedures due to advancements in technology are estimated to further influence
the Asia Pacific Aesthetics Market
expansion. Moreover, the heightened level of affluence in the end-user base is
estimated to contribute to the Asia Pacific Aesthetics Market share in the
upcoming period.
Prominent Companies
ZELTIQ Aesthetics Inc. (U.S.), Galderma
S.A. (Switzerland), Alma Lasers (Israel), Lumenis (Israel), PhotoMedex,
Inc. (U.S.), Cutera (U.S.), Johnson
& Johnson Services, Inc. (U.S.), Solta Medical, Inc. (Canada), Syneron
Medical Ltd. (U.S.), Mentor Worldwide LLC (U.S), Merz Pharma (Germany), Integra
Lifesciences (U.S.), Cynosure Inc. (U.S.), ALLERGAN (Ireland), Sanofi (France),
are some of the leading companies in the Asia Pacific aesthetics market.
Detailed
Regional Analysis
The
regional scrutiny of the Asia Pacific Aesthetics Market consists of North
America, Europe, Africa, and the Middle East. The North American region’s Asia
Pacific Aesthetics Market is estimated to emerge as the principal regional
market in the overall Americas region. The aesthetic industry growth in the
North American region is the outcome of the speedy development in beauty
treatments and various anti-aging cosmetic operations. The Mexican aesthetic
devices market in the region has been bolstered by the mounting interest in
cosmetic techniques, improving healthcare infrastructure, intensifying problem
of skin illnesses, and the increasing number of accomplished board-certified
cosmetic doctors. The regional market of Europe is promoted to be the next highest
gainer in the worldwide market in the future, supported by the collective
support given by the government and the great population of elderly patients
who need improvement in physical form. The substantial healthcare expenditure
is another development-inducing influence in the regional market. The APAC
regional market is estimated to be driven due to the exploding patient
population, swift innovations in technology, and the profusion of lucrative
prospects for global companies in the region. The UAE aesthetic devices market
in the Middle Eastern region is mounting at an encouraging rate, because of the
rising surgeries counting facial fat grafting, breast enlargement, liposuction,
and more. The need for innovative devices and tools to ensure safer and more
effective procedures are projected to guide the Asia Pacific Aesthetics Market
in the region.
Market Segmentation
The Asia Pacific aesthetics market Reporthas been segmented on the basis of
procedures, products, application, and end-user.
The
various procedures in the market are surgical aesthetic procedures and
nonsurgical aesthetic procedures. The surgical aesthetic procedures are
categorized into liposuction, breast augmentation, tummy tuck, eyelid surgery,
breast lift, dermabrasion, and others. On the other hand, the nonsurgical
aesthetic procedures are split into the segments of botulinum toxin, hyaluronic
acid, hair removal, photorejuvenation (IPL), chemical peel, microdermabrasion,
and others.
Product-wise,
the market caters to laser and energy-based devices, skin tightening and body
contouring devices, aesthetic implants, and others. The types of skin
tightening and body contouring devices are liposuction devices, cellulite
reduction devices, cryolipolysis technology, anti-aging device, and others. The
aesthetic implants are fragmented into dental implants, breast implants,
buttock augmentation, transdermal implants, and others.
The
various applications are facial & body contouring, facial & skin
rejuvenation, breast enhancement, scar treatment, reconstructive surgery,
tattoo removal, malignant ascites, vaginal
rejuvenation, and so on.
Depending
on end-user, the market can be segmented based on hospitals & clinics,
dermatology clinics, cosmetic centers, and others.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Market Scope
The home healthcare market is
projected to reach USD 568 billion by 2030 at CAGR of 6.3% during the forecast
period 2022-2030. As per market analysts, the global market is
anticipated to witness growth owing to the factors such as technological
advances in healthcare and diagnosis equipment as well as government
initiatives encouraging home healthcare. However, the market will face
challenges and restraints due to concerns regarding patient safety and
increasing healthcare costs during the forecast period 2022 to 2030.
Drivers and Restrains Impacting Home
Healthcare Market
The rise of the global home healthcare market trendscan be attributed to factors,
such as; adoption of advanced technology in healthcare and diagnosis equipment
and introduction of initiatives by governments to encourage home healthcare
solutions. On the contrary, the home healthcare market is anticipated to face
challenges and restraints owing to rising about patient safety and high healthcare
costs. However, the expansion of the geriatric population in can support the market
rise in years to come.
Competitive Landscape of Home
Healthcare Market
Some reputed companies that are
functioning in the home healthcare market include Abbott (U.S.), Koninklijke
Philips N.V. (The Netherlands), Fresenius SE & Co KGaA (Germany), F.
Hoffmann-La Roche AG (Switzerland), GE Healthcare (U.S.), A&D Company
(Japan), B. Braun Melsungen AG (Germany), McKesson Corporation (U.S.), Omron
Corporation (Japan), Becton Dickinson Company (U.S.), LG Electronics (South
Korea), Medtronic PLC (U.S.), Apple (U.S.), Kinnser Software (U.S.), and 3M
(U.S.) and others. Eminent players are engaged in launching new products and
entering partnerships in the global market and to expand their consumer base.
Segment Analysis of Home Healthcare
Market
The home healthcare market segment
study is based on product, software, and service.
By products, the segments of the home
healthcare market study are screening, therapeutic and testing, and monitoring
products. The segment of therapeutic and testing is sub-segmented into
respiratory therapy equipment, dialysis equipment, insulin delivery devices, IV
equipment, and wound care products among others. The segment of monitoring
products is sub-segmented into event monitors, holter, sleep apnea monitors,
pulse oximeters & heart rate monitors, blood pressure monitors, blood
glucose monitors, and cholesterol monitoring devices among others.
By software, the home healthcare
market study is segmented into hospice solutions, agency software, telehealth
solution, and clinical management systems. The telehealth solution segment can
rise at high growth pace over the years to come.
By services, the global home
healthcare market is segmented into unskilled care services, skilled nursing
services, rehabilitation therapy services, respiratory therapy services,
infusion pregnancy care services, and therapy services. The expansion of the
respiratory therapy services to support market.
Regional Analysis
By
region, the home healthcare market Researchreport covers the latest
trends and growth opportunities across North America, Europe, the Asia Pacific
(APAC), and the Middle East and Africa (MEA). Of these, North America will have
the lion’s share in the market during the forecast period. Numerous factors are
propelling the growth of the home healthcare market in the region, such as the
presence of many leading players, growing awareness about the benefits of home
healthcare services, increasing healthcare expenditures, and rising geriatric
population.
The
global home healthcare market in Europe will have the second-largest share in
the market over the forecast period. Numerous factors are propelling the growth
of the home healthcare market in the region, such as the presence of some
leading players and a well-established healthcare sector, increasing healthcare
expenditures, the resurging economy, advanced technologies, and funding support
for research and development activities.
The
global home healthcare market in the Asia Pacific region will grow at the
fastest pace during the forecast period. Numerous factors are propelling the
growth of the home healthcare market in the region, such as increasing
awareness about the benefits of home healthcare services, increasing geriatric
populace, and the rapid growth of the healthcare sector in China as well as
India.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Stem cells have been acknowledged for their
promising potential toward the development of various cutting-edge treatments
for a number of diseases. As such, stem cell assays have a rapidly growing
market. Stem cell assays are essentially the techniques used for analyzing
living cells by various parameters which ultimately help determine the
biochemical and cellular functioning of cells. This has immense promise in drug
development activities. Market Research Future's study of the market in its
latest report has found that the global stem cell assay market is on track to
register a highly optimistic outlook at a CAGR of 19.8% during the review
period from 2022 to 2030.
Stem cell assays are a promising part of
the biotechnology field, which is growing at a rapid pace. The prevalence of
chronic and several lifestyle diseases has compelled the growth of drug
development activities in an effort to develop effective treatments. Diseases
such as cancer and diabetes are soaring at high rates and the demand for better,
efficient and more affordable treatments are driving the market toward growth.
Healthcare expenditure across the globe is increasing, and advancement in
biotechnology and other medical technologies is highly encouraging of market
growth. Government support toward drug development for chronic diseases has
increased stem
cell assay market research.
Market Segmentation
Market structure is determined by its
various significant sections which, in the report have been segmented on the
basis of product, technology, assay, application, end-user, and region.
Products in the market include flow cytometer, cell imaging systems, automated
cell counter, kits, and others. The kits segment has been sub-segmented and
includes umbilical cord stem cells, induced pluripotent stem cell kits,
mesenchymal stem cell kits, and others.
The technology used in stem cell assays
include microfluidics-based cell trap technologies, microfabricated assisted
technology, synthetic stem cells and others
Assays in the market include cell
identification assays, cell viability & toxicity assays, cell proliferation
assays, cell apoptosis assays, and others.
Applications of stem cell assays can be
found in orthopedic & musculoskeletal spine, dermatology, cardiovascular,
central nervous system, and others.
End-users of stem cell assays include
research organizations, academic institutes, biotechnology industries, academic
institutes, and others.
Regional Analysis
The Americas have captured the dominant
share of the global market. The presence of North America in the region has had
a significant impact on the regions market share possession. The rapid adoption
of advanced medical technologies and the presence of a large patient population
for various chronic diseases drive the Americas' market. Moreover, the regions
healthcare expenditure is rising, and there are several leading players present
in the North American sub-market.
Meanwhile, growing at the fastest pace is
the Asia Pacific regional market. Gradually increasing awareness regarding
advanced medical biotechnology is strongly impacting growth in the region.
Several emerging economies in the region have a rapidly growing biotechnology
sector which fuelling market growth. Findings by the Indian Brand Equity
Foundation suggest that the Indian subcontinent has 2% of the global
biotechnology share. Several opportunities in the region are expected to lead
to market proliferation.
Key Players
Stem
Cell Assay Market players included in MRFR’s report are Cell Biolabs, Inc.,
Thermo Fisher Scientific, Hemogenix, Merck KGaA, Promega Corporation, GE
Healthcare, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cellular
Dynamics International Inc., STEMCELL Technologies Inc., and others
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The nurse
call systems market trends is expected to grow at a CAGR of around 10.9% to
reach a lifetime high value of around USD 2.5 billion by 2027. Nurse call
systems are aimed at alerting the nurses in case of medical emergency
situations or when patients need care. These systems are also used to track a
patient particularly in assisted living or old age centers or are used to give
a signal of a probable situation in case of ambulatory services.
Numerous factors such as growing geriatric
population and rising complexity of hospital operations are expected to drive
the growth of the market.
Some of the industry players offer
integrated equipment, in which the patient data can easily be stored and
retrieved. In February 2015, Rauland Borg Corporation launched a device called
AllTouch responder, which offers nurse call system market with electronic
medical records. The nurse call equipment has evolved over the time owing to
better patient monitoring. The staff members can directly communicate with the
patients to assist them and provide required care, thereby reducing the need to
visit the patient beds for minor requirements. This can eliminate fatigue and
increase the workflow efficiency of the attendant.
Competitive Analysis:
Some of the major companies in the global
nurse call system market include Honeywell International Inc., Austco
Communication Systems Pty Ltd., Hill-Rom Services Inc., Johnson Controls.,
Ascom, CSINC, STANLEY Healthcare, AMETEK, Inc., West-Com Nurse Call System,
Inc, Cornell Communications, Azure Healthcare, Jeron Electronic Systems Inc.,
BEC Integrated Solutions, LLC, Vigil Health Solutions Inc., and Systems
Technologies.
Segmentation:
The nurse call system market is segmented
on type, applications, technology, end users, and region.
Based on the type, the market is segregated
into nurse call integrated communication systems, nurse call buttons, nurse
call intercoms, nurse call mobile systems, and others.
By technology, the market is segmented into
wireless systems and wired systems.
Based on the applications, the market is
segmented into alarms, medical emergency, workflow management, and others.
Based on the end users, it is segmented
into assisted living centers, hospitals & nursing homes, ambulatory care
centers, and others. Of these, hospitals and nursing homes segment is
anticipated to be the larger shareholder in the overall market share. The
growth of the segment is primarily attributable to the rising number of public
as well as private hospitals.
Regional Analysis:
Regionally, the nurse
call system market Research Report is segmented intotheAmericas,
Asia-Pacific, Europe, and Middle East & Africa. Of these, the Americas is
anticipated to dominate the market for nurse call system due to faster demand
for newer technologies and upgradation of nurse call systems in the region.
Additionally, the growing geriatric population and increasing funding for
better healthcare infrastructure in the region. In addition to this, the Europe
is estimated to hold the second leading position in the market owing to
well-developed healthcare industry and investment for increasing number of
hospitals.
Asia-Pacific is anticipated to be the
fastest growing region in the market due to the developing healthcare
facilities in the developing economies and increasing aging population.
According to a report published by Silver Eco in October 2017, in Japan, 27.7
people are elderly or aged.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.